Onate Derrick, Hogan Cassandra, Fitzgerald Kathryn, White Kevin T, Tansey Keith
Lifeward Inc., Marlborough, MA, United States.
United States Department of Veterans Affairs, James A. Haley Veterans' Hospital, Tampa, FL, United States.
Front Rehabil Sci. 2024 Aug 14;5:1428708. doi: 10.3389/fresc.2024.1428708. eCollection 2024.
Approved in 2014 by the Food and Drug Administration (FDA) for use with a trained companion, personal powered exoskeletons (PPE) for individuals with spinal cord injury (SCI) provide an opportunity for the appropriate candidate to ambulate in their home and community. As an adjunct to wheeled mobility, PPE use allows those individuals who desire to ambulate the opportunity to experience the potential physiological and psychosocial benefits of assisted walking outside of a rehabilitation setting. There exists, however, a knowledge gap for clinicians regarding appropriate candidate selection for use, as well as who might benefit from ambulating with a PPE. The purpose of this paper is to provide guidance for clinicians working with individuals living with SCI by outlining an expert consensus for a PPE decision-making algorithm, as well as a discussion of potential physiological and psychosocial benefits from PPE use based on early evidence in publication.
个人动力外骨骼（PPE）于2014年获得美国食品药品监督管理局（FDA）批准，可与经过培训的陪伴者配合使用，为脊髓损伤（SCI）患者提供了在家庭和社区中行走的机会。作为轮式移动辅助工具，使用PPE使那些希望行走的人有机会在康复环境之外体验辅助行走可能带来的生理和心理社会益处。然而，临床医生在合适的使用者选择以及哪些人可能从使用PPE行走中受益方面存在知识空白。本文旨在通过概述PPE决策算法的专家共识，以及根据早期发表的证据讨论使用PPE可能带来的生理和心理社会益处，为治疗SCI患者的临床医生提供指导。
